RxDoctor Payments Data

Paul Dietze, MD

Ophthalmology · Hastings, NENPI 1073525838

Payments from drug & device makers

No general payments reported

No drug or device maker reported general payments to this provider for 2019–2025. That is a common and unremarkable result.

How this compares

$0 in reported general payments places this provider in the 0th percentile of 105 ophthalmology providers in Nebraska.

See all ophthalmology providers in Nebraska

Medicare billing

Part B allowed, 2024
$516,272
Medicare patients
1,730
Services billed
5,125

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Prednisolone Acetate466$19,349
XiidraLifitegrast19$19,120
LumiganBimatoprost49$12,069
Latanoprost1,134$11,559
RhopressaNetarsudil Mesylate25$8,001
CombiganBrimonidine Tartrate/Timolol29$6,669
Ofloxacin373$4,633
IlevroNepafenac12$4,260
Travoprost35$3,689
Ketorolac Tromethamine83$3,608
Dorzolamide Hcl187$3,292
VyzultaLatanoprostene Bunod13$3,167
TobradexTobramycin/Dexamethasone12$3,082
Brinzolamide11$2,580
Brimonidine Tartrate121$2,344

Paid to pharmacies, not to this prescriber.

Other ophthalmology in Hastings

See the full list for Nebraska

Where these figures come from

Is this you, or does something look wrong? →